PEPG
Price:
$4.41
Market Cap:
$143.75M
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2022-05-06
Stock Exchange
NASDAQ
Ticker
PEPG
According to PepGen Inc.’s latest financial reports and current stock price. The company's current ROE is -60.17%. This represents a change of 288.94% compared to the average of -15.47% of the last 4 quarters.
The mean historical ROE of PepGen Inc. over the last ten years is -37.11%. The current -60.17% ROE has changed 62.15% with respect to the historical average. Over the past ten years (40 quarters), PEPG's ROE was at its highest in in the March 2020 quarter at 0%. The ROE was at its lowest in in the March 2021 quarter at -67.69%.
Average
-37.11%
Median
-34.81%
Minimum
-72.52%
Maximum
-19.24%
Discovering the peaks and valleys of PepGen Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 88.51%
Maximum Annual ROE = -19.24%
Minimum Annual Increase = -44.71%
Minimum Annual ROE = -72.52%
Year | ROE | Change |
---|---|---|
2023 | -72.52% | 88.51% |
2022 | -38.47% | 87.68% |
2021 | -20.50% | 6.51% |
2020 | -19.24% | -44.71% |
The current ROE of PepGen Inc. (PEPG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-43.83%
5-year avg
-37.11%
10-year avg
-37.11%
PepGen Inc.’s ROE is greater than PMV Pharmaceuticals, Inc. (-24.20%), greater than Eliem Therapeutics, Inc. (-47.03%), greater than MediciNova, Inc. (-20.70%), greater than Pharvaris N.V. (-38.27%), greater than Molecular Partners AG (-39.16%), greater than Mineralys Therapeutics, Inc. (-55.92%), greater than AN2 Therapeutics, Inc. (-57.63%), greater than Century Therapeutics, Inc. (-66.58%), greater than Edgewise Therapeutics, Inc. (-26.83%), greater than C4 Therapeutics, Inc. (-42.45%), greater than Cullinan Oncology, Inc. (-26.54%), greater than Tyra Biosciences, Inc. (-25.14%), greater than Compass Therapeutics, Inc. (-28.67%), greater than Vigil Neuroscience, Inc. (-83.89%), greater than PureTech Health plc (-26.28%), less than Entrada Therapeutics, Inc. (16.11%), greater than Rallybio Corporation (-77.39%),
Company | ROE | Market cap |
---|---|---|
-24.20% | $83.31M | |
-47.03% | $342.68M | |
-20.70% | $104.47M | |
-38.27% | $1.20B | |
-39.16% | $216.81M | |
-55.92% | $621.09M | |
-57.63% | $39.99M | |
-66.58% | $102.89M | |
-26.83% | $3.05B | |
-42.45% | $300.00M | |
-26.54% | $730.17M | |
-25.14% | $801.05M | |
-28.67% | $205.01M | |
-83.89% | $130.41M | |
-26.28% | $539.86M | |
16.11% | $703.50M | |
-77.39% | $42.32M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PepGen Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like PepGen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is PepGen Inc.'s ROE?
How is the ROE calculated for PepGen Inc. (PEPG)?
What is the highest ROE for PepGen Inc. (PEPG)?
What is the 3-year average ROE for PepGen Inc. (PEPG)?
What is the 5-year average ROE for PepGen Inc. (PEPG)?
How does the current ROE for PepGen Inc. (PEPG) compare to its historical average?